SUPPLEMENTARY INFORMATION Associated with

Similar documents
Functional Heartburn and Dyspepsia

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital

Outline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments

Non-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics

J Neurogastroenterol Motil, Vol. 17 No. 3 July, 2011 DOI: /jnm Journal of Neurogastroenterology and Motility

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

Angie Jefferson Registered Dietitian & Consultant Nutritionist

Irritable Bowel Syndrome

FUNCTIONAL DISORDERS ROME IV CRITERIA AND DIAGNOSTIC QUESTIONNAIRE DDW 2016,REVIEW. Presented by; Marjan Mokhtare Gastroenterologist, IUMS

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Irritable Bowel Syndrome. Mustafa Giaffer March 2017

Functional Dyspepsia. Norbert Welkovics Heine van der Walt

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

IBS: overview and assessment of pain outcomes and implications for inclusion criteria

Functional Dyspepsia

IBS - Definition. Chronic functional disorder of GI generally characterized by:

PELVIC PAIN : Gastroenterological Conditions

Managing constipation in residential care

Subgroups of Dyspepsia

Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?

Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders.

PELVIC PAIN : Gastroenterological Conditions

UNDERSTANDING IBS AND CC Implications for diagnosis and management

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Research Article Prevalence of Functional Gastrointestinal Disorders according to Rome III Criteria in Italian Morbidly Obese Patients

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?

SYMPROIC (naldemedine tosylate) oral capsule

Correlation of bowel habits with physical activity and fibre intake

Elderly Man With Chronic Constipation

Biofeedback for Pelvic Floor Disorders and Incontinence

There are clues to help to decide if the bellyache is a medical problem:

COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN

A Guide to Gastrointestinal Motility Disorders

Management of Functional Dyspepsia (FD)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Concomitant Functional Gastrointestinal Symptoms Influence Psychological Status in Korean Migraine Patients

1.* Have you been bothered by PAIN OR DISCOMFORT IN YOUR UPPER ABDOMEN OR THE PIT OF YOUR STOMACH during the past week?

DOCTOR DISCUSSION GUIDE

Grigoris Leontiadis, MD PhD. McMaster University Upper Gastrointestinal and Pancreatic Diseases Cochrane Group

Dyspepsia and Chronic Gastritis

Mary Ferreira. Clinical Case Report Competition. Utopia Academy. First Place Winner. December 2011

HOW TO NATURALLY TREAT INDIGESTION YOGI CAMERON

Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI

An Approach to Abdominal Pain

Definition, Pathogenesis, and Management of That Cursed Dyspepsia

from Bowel Control Problems twitter.com/voicesforpfd

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

The speed of eating and functional dyspepsia

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary

Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.

Emerging Treatments for IBS-C and Clinical Trial Endpoints

Functional bowel disorders and functional abdominal pain

Reflux of gastric contents, particularly acid, into the esophagus

Optimizing the Upper GI: Mind, Mouth, and Stomach What Can Go Wrong With Dr. Ritamarie Loscalzo

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM

ABDOMINAL PAIN, CHRONIC

Abdominal massage for the treatment of constipation (Protocol)

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

The Role of Food in the Functional Gastrointestinal Disorders

Common Gastrointestinal Problems in the Elderly

The Digestive System or tract extends from the mouth to the anus.

Low FODMAP Dietary Approach For FGD/IBS. Our Experience. Charlotte McCamphill 19 th February 2015

Objectives. Identify age-related changes in the gastrointestinal tract

Digestion. Text. What You Don t Know Can Hurt You!

Prepared by: Dr Katherine Brown Fir Lea House Whitecross Newquay Cornwall TR8 4LW. Date: 17/10/2016

IRONWOOD AND FOREST ANNOUNCE POSITIVE LINACLOTIDE RESULTS FROM PHASE 3 TRIAL IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION

June By: Reza Gholami

Bloating, Flatulence, and

pissn: eissn: Journal of Neurogastroenterology and Motility

Intestinal, non-intestinal, and extra-digestive response to linaclotide in patients with IBS-C: results at Week 4 predict sustained response

Alternating bowel pattern: what do people mean?

Epidemiology and Impact of IBS

ACG Clinical Guideline: Management of Benign Anorectal Disorders

Clinical Manifestations of Gastrointestinal Disorders. Awni Taleb Abu sneineh

Zelmac Learning System: Module 2

Drug Evaluation. Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

190 Index Case studies, abdominal pain, 2 Crohn s disease, 2 3, cyclic vomiting syndrome (CVS), 2 fecal incontinence (FI), 2 medical c

New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome

Cigarette Smoking and its Association with Overlapping Gastroesophageal Reflux Disease, Functional Dyspepsia, or Irritable Bowel Syndrome

Accepted Article. Irritable bowel syndrome (IBS) subtypes: Nothing. Fermín Mearin Manrique. DOI: /reed /2016 Link: PDF

Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN

HELICOBACTER PYLORI; PATIENTS WITH FUNCTIONAL DYSPEPSIA

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES

Dyspepsia: alarm symptoms, investigation and management

IBS. Patient INFO. A Guide to Irritable Bowel Syndrome

METABOLIC ASSESSMENT FORM

Use of Functional Electrical Stimulation (FES) for chronic constipation & People with Multiple Sclerosis (PwMS)

Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514

ABDOMINAL PAIN, CHRONIC

Real World Efficacy and Tolerability of Acotiamide in Relieving Multiple and Overlapping Symptoms in Patients of Functional Dyspepsia

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease

Transcription:

Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS 1 Recurrent abdominal pain or discomfort at least 3 days per month in the last 3 months associated with 2 or more of the following: 1. Improvement with defecation 2. Onset associated with a change in frequency of stool 3. Onset associated with a change in form (appearance) of stool 1 Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis Diagnostic criteria for IBS 1 Recurrent abdominal pain, occurring on average, at least 1 day per week in the last 3 months, and associated with 2 or more of the following: 1. Related to defecation 2. Associated with a change in frequency of stool. 3. Associated with a change in form (appearance) of stool. 1 Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis Diagnostic criteria for functional constipation 2 1. Must include 2 or more of the following: a. Straining during at least 25% of defecations b. Lumpy or hard stools in at least 25% of defecations c. Sensation of incomplete evacuation for at least 25% of defaecations d. Sensation of anorectal obstruction/blockage for at least 25% of defecations e. Manual manoeuvres to facilitate at least 25% of defecations (such as digital evacuation, support of the pelvic floor) f. Fewer than 3 defecations per week Diagnostic criteria for functional constipation 2 1. Must include 2 or more of the following: a. Straining during more than one- fourth (25%) of defecations b. Lumpy or hard stools (Bristol stool form scale 1 or 2) more than one- fourth (25%) of defecations c. Sensation of incomplete evacuation more than one- fourth (25%) of defecations d. Sensation of anorectal obstruction/blockage more than one- fourth (25%) of defaecations e. Manual manoeuvres to facilitate more than one- fourth (25%) of defecations (such as digital evacuation, or support of the pelvic floor) f. Fewer than 3 spontaneous bowel movements per week

2. Loose stools are rarely present without the use of laxatives 3. There are insufficient criteria for IBS 2 Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis 2. Loose stools are rarely present without the use of laxatives 3. Insufficient criteria for IBS 2 Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis Diagnostic criteria for functional dyspepsia 3 1. One or more of the following: a. Bothersome postprandial fullness b. Early satiation c. Epigastric pain d. Epigastric burning AND 2. No evidence of structural disease that explains the symptoms 3 Criteria fulfilled for the last 3 months with symptom onset at least 6 Diagnostic criteria for functional dyspepsia 3 1. One or more of the following: a. Bothersome postprandial fullness b. Bothersome early satiation c. Bothersome epigastric pain d. Bothersome epigastric burning AND 2. No evidence of structural disease that explains the symptoms 3 Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis Postprandial distress syndrome diagnostic criteria 4 Must include one or both of the following: 1. Bothersome postprandial fullness, occurring after ordinary sized meals, at least several times per week Postprandial distress syndrome diagnostic criteria 4 Must include one or both of the following at least 3 days per week: 1. Bothersome postprandial fullness 2. Bothersome early satiation

2. Early satiation that prevents finishing a regular meal, at least several times per week 4 Criteria fulfilled for the last 3 months with symptom onset at least 6 No evidence of organic, systemic, or metabolic disease that explains the symptoms (including at upper endoscopy) 4 Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis Upper abdominal bloating or postprandial nausea or excessive belching can be present Epigastric pain syndrome may coexist Postprandial epigastric pain or burning, epigastric bloating, excessive belching, and nausea can be present but vomiting warrants consideration of another disorder Heartburn is not a dyspeptic symptom but may often coexist Symptoms that are relieved by evacuation of faeces or gas should generally not be considered as part of dyspepsia Other individual digestive symptoms or groups of symptoms, for example, from gastroesophageal reflux disease and the irritable bowel syndrome may coexist with PDS Epigastric pain syndrome diagnostic criteria 5 Must include all of the following: 1. Pain or burning localised to the epigastrium of at least moderate severity at least once per week 2. The pain is intermittent 3. Not generalised or localised to other abdominal or chest regions 4. Not relieved by defaecation or passage of flatus 5. Not fulfilling criteria for gallbladder and sphincter of Oddi disorders Epigastric pain syndrome diagnostic criteria 5 Must include at least 1 of the following symptoms at least 1 day a week: 1. Bothersome epigastric pain AND/OR 2. Bothersome epigastric burning 5 No evidence of organic, systemic, or metabolic disease that is likely to

5 Criteria fulfilled for the last 3 months with symptom onset at least 6 The pain may be of a burning quality but without a retrosternal component The pain is commonly induced or relieved by ingestion of a meal but may occur while fasting Postprandial distress syndrome may coexist explain the symptoms (including at upper endoscopy). Criteria fulfilled for the last 3 months with symptom onset at least 6. Pain may be induced by ingestion of a meal, relieved by ingestion of a meal, or may occur while fasting Postprandial epigastric bloating, belching, and nausea can also be present Persistent vomiting likely suggests another disorder Heartburn is not a dyspeptic symptom but may often coexist The pain does not fulfil biliary pain criteria Symptoms that are relieved by evacuation of faeces or gas generally should not be considered as part of dyspepsia Other digestive symptoms (such as from gastroesophageal reflux disease and the irritable bowel syndrome) may coexist with epigastric pain syndrome With permission from Elsevier Longstreth. G.F. et al. Functional bowel disorders. Gastroenterology 130, 1480-1491 (2006), Tack, J. et al. Functional gastroduodenal disorders. Gastroenterology 130, 1466-1479 (2006), Mearin, F. et al. Bowel disorders. Gastroenterology 150, 1393-1407 (2016) and Stanghellini, V. et al. Gastroduodenal disorders. Gastroenterology 150, 1380-1392 (2016). REFERENCES S1. Longstreth. G.F. et al. Functional bowel disorders. Gastroenterology 130, 1480-1491 (2006). S2. Tack, J. et al. Functional gastroduodenal disorders. Gastroenterology 130, 1466-1479 (2006).

S3. Mearin, F. et al. Bowel disorders. Gastroenterology 150, 1393-1407 (2016). S4. Stanghellini, V. et al. Gastroduodenal disorders. Gastroenterology 150, 1380-1392 (2016).